{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:57:06Z","timestamp":1790467026692,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.canlet.2009.09.009","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T05:05:57Z","timestamp":1255410357000},"page":"204-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells"],"prefix":"10.1016","volume":"290","author":[{"given":"Ti","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Tao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun-Xiu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Long","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-You","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2009.09.009_bib1","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2009.09.009_bib2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1245\/s10434-007-9366-z","article-title":"High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies","volume":"14","author":"Poon","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.canlet.2009.09.009_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/jhep.2000.8525","article-title":"High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential","volume":"32","author":"Wang","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2009.09.009_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1091-255X(03)00072-6","article-title":"Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice","volume":"7","author":"Wang","year":"2003","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.canlet.2009.09.009_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000082928","article-title":"Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells","volume":"67","author":"Wu","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.canlet.2009.09.009_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00432-004-0615-2","article-title":"Interferon alpha 2a downregulates VEGF expression through PI3 kinase and MAP kinase signaling pathways","volume":"131","author":"Wu","year":"2005","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2009.09.009_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cncr.20004","article-title":"Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors","volume":"100","author":"Lin","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2009.09.009_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00432-006-0091-y","article-title":"Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial","volume":"132","author":"Sun","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2009.09.009_bib9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/01.sla.0000245829.00977.45","article-title":"A randomized, Controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma","volume":"245","author":"Lo","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2009.09.009_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","article-title":"Tumorigenesis and the angiogenic switch","volume":"3","author":"Bergers","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2009.09.009_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nm0603-661","article-title":"Endothelial signaling during development","volume":"9","author":"Cleaver","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2009.09.009_bib12","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1158\/1078-0432.CCR-05-0944","article-title":"Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.009_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7","article-title":"Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues","volume":"66","author":"Sun","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2009.09.009_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.bjc.6690769","article-title":"New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis","volume":"81","author":"Tian","year":"1999","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2009.09.009_bib15","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3748\/wjg.v7.i5.630","article-title":"Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97","volume":"7","author":"Li","year":"2001","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2009.09.009_bib16","doi-asserted-by":"crossref","first-page":"25195","DOI":"10.1074\/jbc.M200921200","article-title":"HIV-1-Tat protein activates phosphatidylinositol 3-kinase\/ AKT-dependent survival pathways in Kaposi\u2019s sarcoma cells","volume":"277","author":"Deregibus","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2009.09.009_bib17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/jnci\/95.6.458","article-title":"Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases","volume":"95","author":"Uehara","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2009.09.009_bib18","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1158\/0008-5472.CAN-03-3763","article-title":"Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice","volume":"64","author":"Kim","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.009_bib19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/429618a","article-title":"Molecular medicine: the writing is on the vessel wall","volume":"429","author":"Contag","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2009.09.009_bib20","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-03-3863","article-title":"Activation of the platelet-derived growth factor-receptor enhances survival of murine bone endothelial cells","volume":"64","author":"Langley","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.009_bib21","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1158\/0008-5472.CAN-05-1698","article-title":"Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model","volume":"65","author":"Yokoi","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.009_bib22","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.4049\/jimmunol.172.3.1699","article-title":"IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA","volume":"172","author":"Kaiser","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2009.09.009_bib23","first-page":"1858","article-title":"Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice","volume":"9","author":"Solorzano","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2009.09.009_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1083\/jcb.200603176","article-title":"Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3","volume":"175","author":"Saunders","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2009.09.009_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2009.09.009_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0021-9150(84)90101-1","article-title":"Surface determinants of low density lipoprotein uptake by endothelial cells","volume":"53","author":"Gorog","year":"1984","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.canlet.2009.09.009_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.ATV.16.4.585","article-title":"Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1","volume":"16","author":"Smalley","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.canlet.2009.09.009_bib28","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2005-01-0010","article-title":"Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature","volume":"105","author":"May","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2009.09.009_bib29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1083\/jcb.140.6.1475","article-title":"Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization","volume":"140","author":"Navarro","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2009.09.009_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/01.sla.0000231723.81218.72","article-title":"Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin","volume":"244","author":"Menon","year":"2006","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2009.09.009_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ncb1486","article-title":"VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin","volume":"8","author":"Gavard","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2009.09.009_bib32","doi-asserted-by":"crossref","first-page":"16230","DOI":"10.1074\/jbc.M212591200","article-title":"VE-cadherin-induced Cdc42 signaling regulates formation of membrane protrusions in endothelial cells","volume":"278","author":"Kouklis","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509005977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383509005977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:29:30Z","timestamp":1759591770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383509005977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0304383509005977"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2009.09.009","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2009.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}